AAAAAA
Results: 1-25/48
Authors:
Reaven, GM
Citation: Gm. Reaven, Why is it important to be insulin sensitive?, DIABETE MET, 27(2), 2001, pp. 191-192
Authors:
Reaven, GM
Citation: Gm. Reaven, Insulin resistance: why is it important to treat?, DIABETE MET, 27(2), 2001, pp. 247-253
Authors:
Hollenberg, NK
Anzalone, DA
Falkner, B
Fisher, NDL
Hopkins, PN
Hsueh, W
Hutchinson, H
Krauss, RM
Price, DA
Raskin, P
Reaven, GM
Citation: Nk. Hollenberg et al., Familial factors in the antihypertensive response to lisinopril, AM J HYPERT, 14(3), 2001, pp. 218-223
Authors:
Ai, M
Tanaka, A
Ogita, K
Sekinc, M
Numano, F
Numano, F
Reaven, GM
Citation: M. Ai et al., Relationship between plasma insulin concentration and plasma remnant lipoprotein response to an oral fat load in patients with type 2 diabetes, J AM COL C, 38(6), 2001, pp. 1628-1632
Authors:
McLaughlin, T
Abbasi, F
Lamendola, C
Kim, HS
Reaven, GM
Citation: T. Mclaughlin et al., Metabolic changes following sibutramine-assisted weight loss in obese individuals: Role of plasma free fatty acids in the insulin resistance of obesity, METABOLISM, 50(7), 2001, pp. 819-824
Authors:
Reaven, GM
Abbasi, F
Bernhart, S
Coulston, A
Darnell, B
Dashti, N
Kim, HS
Kulkarni, K
Lamendola, C
McLaughlin, T
Osterlund, L
Schaff, P
Segrest, J
Citation: Gm. Reaven et al., Insulin resistance, dietary cholesterol, and cholesterol concentration in postmenopausal women, METABOLISM, 50(5), 2001, pp. 594-597
Authors:
Cataldo, NA
Abbasi, F
McLaughlin, TL
Lamendola, C
Reaven, GM
Citation: Na. Cataldo et al., Improvement in insulin sensitivity followed by ovulation and pregnancy in a woman with polycystic ovary syndrome who was treated with rosiglitazone, FERT STERIL, 76(5), 2001, pp. 1057-1059
Authors:
Kim, HS
Abbasi, F
Lamendola, C
McLaughlin, T
Reaven, GM
Citation: Hs. Kim et al., Effect of insulin resistance on postprandial elevations of remnant lipoprotein concentrations in postmenopausal women, AM J CLIN N, 74(5), 2001, pp. 592-595
Authors:
Abbasi, F
Asagmi, T
Cooke, JP
Lamendola, C
McLaughlin, T
Reaven, GM
Stuehlinger, M
Tsao, PS
Citation: F. Abbasi et al., Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus, AM J CARD, 88(10), 2001, pp. 1201
Authors:
Santos, RF
Nomizo, R
Oliveira, E
Ursich, M
Wajchenberg, B
Reaven, GM
Azhar, S
Citation: Rf. Santos et al., Erythrocyte insulin receptor tyrosine kinase activity is increased in glyburide-treated patients with type 2 diabetes in good glycaemic control, DIABET OB M, 2(4), 2000, pp. 237-241
Authors:
Reaven, GM
Citation: Gm. Reaven, Insulin resistance - how important is it to treat?, EXP CL E D, 108, 2000, pp. S274-S280
Authors:
Facchini, FS
Hua, NW
Reaven, GM
Stoohs, RA
Citation: Fs. Facchini et al., Hyperinsulinemia: The missing link among oxidative stress and age-related diseases?, FREE RAD B, 29(12), 2000, pp. 1302-1306
Authors:
Gowri, MS
Azhar, RK
Kraemer, FB
Reaven, GM
Azhar, S
Citation: Ms. Gowri et al., Masoprocol decreases rat lipolytic activity by decreasing the phosphorylation of HSL, AM J P-ENDO, 279(3), 2000, pp. E593-E600
Authors:
Jones, CNO
Abbasi, F
Carantoni, M
Polonsky, KS
Reaven, GM
Citation: Cno. Jones et al., Roles of insulin resistance and obesity in regulation of plasma insulin concentrations, AM J P-ENDO, 278(3), 2000, pp. E501-E508
Authors:
Reaven, GM
Citation: Gm. Reaven, Are the results really different?, DIABET CARE, 23(7), 2000, pp. 1040-1040
Authors:
Yeni-Komshian, H
Carantoni, M
Abbasi, F
Reaven, GM
Citation: H. Yeni-komshian et al., Relationship between several surrogate estimates of insulin resistance andquantification of insulin-mediated glucose disposal in 490 healthy nondiabetic volunteers, DIABET CARE, 23(2), 2000, pp. 171-175
Authors:
Scribner, KA
Gadbois, TM
Gowri, M
Azhar, S
Reaven, GM
Citation: Ka. Scribner et al., Masoprocol decreases serum triglyceride concentrations in rats with fructose-induced hypertriglyceridemia, METABOLISM, 49(9), 2000, pp. 1106-1110
Authors:
Zavaroni, I
Platti, PM
Monti, LD
Gasparini, P
Barilli, LA
Massironi, P
Ardigo, D
Valsecchi, G
Delsignore, R
Reaven, GM
Citation: I. Zavaroni et al., Plasma nitric oxide concentrations are elevated in insulin-resistant healthy subjects, METABOLISM, 49(8), 2000, pp. 959-961
Authors:
Zavaroni, I
Gasparini, P
Barilli, AI
Massironi, P
Campanini, C
Carantoni, M
Delsignore, R
Reaven, GM
Citation: I. Zavaroni et al., Comparison of fasting plasma leptin concentrations in healthy subjects with high and low plasma insulin, METABOLISM, 49(4), 2000, pp. 499-502
Authors:
Abbasi, F
Carantoni, M
McLaughlin, T
Reaven, GM
Citation: F. Abbasi et al., Plasma insulin concentration is more tightly linked to plasma leptin concentration than is the body mass index, METABOLISM, 49(4), 2000, pp. 544-547
Authors:
Rosolova, H
Mayer, O
Reaven, GM
Citation: H. Rosolova et al., Insulin-mediated glucose disposal is decreased in normal subjects with relatively low plasma magnesium concentrations, METABOLISM, 49(3), 2000, pp. 418-420
Authors:
Abbasi, F
McLaughlin, T
Lamendola, C
Reaven, GM
Citation: F. Abbasi et al., Insulin regulation of plasma free fatty acid concentrations is abnormal inhealthy subjects with muscle insulin resistance, METABOLISM, 49(2), 2000, pp. 151-154
Authors:
Reed, MJ
Meszaros, K
Entes, LJ
Claypool, MD
Pinkett, JG
Gadbois, TM
Reaven, GM
Citation: Mj. Reed et al., A new rat model of type 2 diabetes: The fat-fed, streptozotocin-treated rat, METABOLISM, 49(11), 2000, pp. 1390-1394
Authors:
Abbasi, F
McLaughlin, T
Lamendola, C
Reaven, GM
Citation: F. Abbasi et al., The relationship between glucose disposal in response to physiological hyperinsulinemia and basal glucose and free fatty acid concentrations in healthy volunteers, J CLIN END, 85(3), 2000, pp. 1251-1254
Authors:
Ai, M
Tanaka, A
Ogita, K
Sekine, M
Numano, F
Numano, F
Reaven, GM
Citation: M. Ai et al., Relationship between hyperinsulinemia and remnant lipoprotein concentrations in patients with impaired glucose tolerance, J CLIN END, 85(10), 2000, pp. 3557-3560